Immediate Impact
1 from Science/Nature 47 standout
Citing Papers
Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial
2023 Standout
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
2022 Standout
Works of Enzo Acuña being referenced
Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo
1996
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Enzo Acuña | 311 | 183 | 79 | 84 | 38 | 419 | |
| M.C. Thorndyke | 97 | 120 | 10 | 216 | 31 | 423 | |
| Agustín A. Rojas‐Herrera | 300 | 133 | 75 | 108 | 47 | 386 | |
| T. R. Ruhnke | 446 | 214 | 216 | 56 | 28 | 461 | |
| Paola E. Braicovich | 361 | 155 | 74 | 91 | 36 | 390 | |
| R. A. Campbell | 434 | 163 | 217 | 52 | 27 | 451 | |
| Marine J. Briand | 278 | 139 | 58 | 27 | 23 | 377 | |
| Micah D. Bakenhaster | 367 | 106 | 54 | 53 | 36 | 391 | |
| Pedro Torres | 312 | 303 | 86 | 77 | 29 | 440 | |
| Valentin N’douba | 235 | 47 | 178 | 212 | 54 | 451 | |
| H. J. Squires | 248 | 240 | 101 | 72 | 31 | 381 |
All Works
Login with ORCID to disown or claim papers
Loading papers...